1. Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic
    Nadezhda Ivanova et al, 2022, Pharmaceutics CrossRef
  2. Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection
    Sherif A. El-Kafrawy et al, 2021, Pharmaceuticals CrossRef
  3. COVID‑19 vaccination and IgG and IgA antibody dynamics in healthcare workers
    Sabina Zurac et al, 2021, Molecular Medicine Reports CrossRef
  4. Tecnología IgY: Estrategia en el tratamiento de enfermedades infecciosas humanas
    Nathaly Cruz, Tipantiza et al, 2021, Bionatura CrossRef
  5. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy
    Carolina Constantin et al, 2021, Nanomedicine CrossRef
  6. Production and characteristics of a novel chicken egg yolk antibody (IgY) against periodontitis-associated pathogens
    Xiangguang Li et al, 2020, Journal of Oral Microbiology CrossRef
  7. Peptides and pseudopeptide ligands: a powerful toolbox for the affinity purification of current and next-generation biotherapeutics
    Wenning Chu et al, 2021, Journal of Chromatography A CrossRef
  8. Herbal medicine, a reliable support in COVID therapy
    Alice Grigore et al, 2020, Journal of Immunoassay and Immunochemistry CrossRef
  9. The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro
    Jinglu Lyu et al, 2021, International Immunopharmacology CrossRef
  10. Unconventional Therapy with IgY in a Psoriatic Mouse Model Targeting Gut Microbiome
    Mihaela Surcel et al, 2021, Journal of Personalized Medicine CrossRef
  11. Back to basics in COVID‐19: Antigens and antibodies—Completing the puzzle
    Monica Neagu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
  12. The bumpy road to achieve herd immunity in COVID-19
    Monica Neagu, 2020, Journal of Immunoassay and Immunochemistry CrossRef
  13. Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
    Lucia Lee et al, 2021, Frontiers in Immunology CrossRef
  14. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines
    Monica Neagu et al, 2021, International Journal of Environmental Research and Public Health CrossRef
  15. SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice
    Sherif A. El-Kafrawy et al, 2022, PLOS Pathogens CrossRef
  16. Targets and assay types for COVID-19 diagnosis
    Marinela Bostan et al, 2020, Journal of Immunoassay and Immunochemistry CrossRef
  17. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
    Gunawan Widjaja et al, 2021, Human Immunology CrossRef
  18. Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?
    José M. Pérez de la Lastra et al, 2020, Vaccines CrossRef
  19. Drug repurposing for COVID-19 via knowledge graph completion
    Rui Zhang et al, 2021, Journal of Biomedical Informatics CrossRef
  20. Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping
    Yan Lu et al, 2020, Journal of Immunology Research CrossRef
  21. IgY technology: Methods for developing and evaluating avian immunoglobulins for the in vitro detection of biomolecules
    Chrysoula-Evangelia Karachaliou et al, 2021, World Journal of Methodology CrossRef
  22. Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo
    Chia-Tsui Yeh et al, 2022, Biomedicines CrossRef
  23. Scientometric analysis and perspective of IgY technology study
    Rao Wu et al, 2022, Poultry Science CrossRef
  24. Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19
    Andres Agurto-Arteaga et al, 2022, Frontiers in Immunology CrossRef
  25. Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
    Chad Artman et al, 2022, Viruses CrossRef